Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
79.2M
-
Number of holders
-
179
-
Total 13F shares, excl. options
-
85.1M
-
Shares change
-
-94K
-
Total reported value, excl. options
-
$2.47B
-
Value change
-
-$415K
-
Put/Call ratio
-
0.75
-
Number of buys
-
81
-
Number of sells
-
-87
-
Price
-
$29.09
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT) as of Q1 2024
212 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share as of Q1 2024.
PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT) has 179 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 85.1M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (9.37M shares), WELLINGTON MANAGEMENT GROUP LLP (8.9M shares), BlackRock Inc. (7.57M shares), RTW INVESTMENTS, LP (7.42M shares), ARMISTICE CAPITAL, LLC (6.76M shares), STATE STREET CORP (4.11M shares), Camber Capital Management LP (4M shares), COWEN AND COMPANY, LLC (3.73M shares), JANUS HENDERSON GROUP PLC (3.67M shares), and MORGAN STANLEY (2.06M shares).
This table shows the top 179 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.